Credit Suisse’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.2M | Buy |
|
|||||
|
2023
Q4 | $2.36M | Buy |
|
|||||
|
2023
Q3 | $2.15M | Sell |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $782K | Buy |
|
|||||
|
2022
Q4 | $868K | Buy |
|
|||||
|
2022
Q3 | $225K | Buy |
|
|||||
|
2022
Q2 | $145K | Buy |
|
|||||
|
2022
Q1 | $192K | Buy |
|
|||||
|
2021
Q4 | $200K | Buy |
|
|||||
|
2021
Q3 | $186K | Sell |
|
|||||
|
2021
Q2 | $724K | Buy |
|
|||||
|
2021
Q1 | $775K | Sell |
|
|||||
|
2020
Q4 | $3.03M | Buy |
|
|||||
|
2020
Q3 | $1.38M | Buy |
|
|||||
|
2020
Q2 | $325K | Buy |
|